Guobang Pharma Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Guobang Pharma Ltd.

Why is Guobang Pharma Ltd. ?

With ROE of 10.11%, it has a very attractive valuation with a 0.83 Price to Book Value

Over the past year, while the stock has generated a return of 13.19%, its profits have risen by 26.1% ; the PEG ratio of the company is 0.3
At the current price, the company has a high dividend yield of 2.7

Real-Time Research Report

Verdict Report

How much should you buy?

Overall Portfolio exposure to Guobang Pharma Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Guobang Pharma Ltd. for you?

Medium Risk, High Return

Absolute

Risk Adjusted

Volatility

Guobang Pharma Ltd.

14.39%

1.35

25.40%

China Shanghai Composite

15.14%

0.89

14.48%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

6.51%

EBIT Growth (5y)

-0.07%

EBIT to Interest (avg)

41.72

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.02

Sales to Capital Employed (avg)

0.59

Tax Ratio

11.75%

Dividend Payout Ratio

43.31%

Pledged Shares

Institutional Holding

ROCE (avg)

12.80%

ROE (avg)

10.18%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.83

EV to EBIT

7.26

EV to EBITDA

4.80

EV to Capital Employed

0.83

EV to Sales

1.08

PEG Ratio

0.32

Dividend Yield

2.73%

ROCE (Latest)

11.39%

ROE (Latest)

10.11%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Sideways

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

13What is working for the Company

INTEREST COVERAGE RATIO(Q)

Highest at 6,175.65

OPERATING CASH FLOW(Y)

Highest at CNY 1,062.55 MM

OPERATING PROFIT MARGIN(Q)

Highest at 24.5 %

RAW MATERIAL COST(Y)

Fallen by -6.57% (YoY

NET SALES(Q)

Highest at CNY 1,571.72 MM

OPERATING PROFIT(Q)

Highest at CNY 385.14 MM

PRE-TAX PROFIT(Q)

Highest at CNY 269.84 MM

NET PROFIT(Q)

Highest at CNY 236.44 MM

EPS(Q)

Highest at CNY 0.44

-4What is not working for the Company

DEBTORS TURNOVER RATIO(HY)

Lowest at 4.21%

INTEREST(Q)

At CNY 6.24 MM has Grown at 11.04%

Here's what is working for Guobang Pharma Ltd.

Interest Coverage Ratio

Highest at 6,175.65 and Grown

In each period in the last five periods

MOJO Watch

The company's ability to manage interest payments is improving

Operating Profit to Interest

Operating Profit Margin

Highest at 24.5 % and Grown

In each period in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Operating Cash Flow

Highest at CNY 1,062.55 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Net Sales

Highest at CNY 1,571.72 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Operating Profit

Highest at CNY 385.14 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (CNY MM)

Pre-Tax Profit

Highest at CNY 269.84 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 236.44 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.44

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Raw Material Cost

Fallen by -6.57% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Guobang Pharma Ltd.

Interest

At CNY 6.24 MM has Grown at 11.04%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Debtors Turnover Ratio

Lowest at 4.21% and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio